Literature DB >> 16131546

Regulation of synaptic plasticity in a schizophrenia model.

Barbara Gisabella1, Vadim Y Bolshakov, Francine M Benes.   

Abstract

The pathology of schizophrenia is characterized by increased hippocampal activity at baseline and during auditory hallucinations. Animal-model studies in which the flow of activity to the hippocampus is increased through decreased amygdalar GABAergic inhibition have shown alterations of hippocampal circuitry similar to schizophrenia, but the functional importance of this phenomenon remains unclear. We provide evidence of decreased hippocampal feed-forward and tonic GABA-mediated inhibition in this animal model, complementing increased hippocampal activity seen in neuroimaging and postmortem studies. We demonstrate that GABA dysfunction increases long-term potentiation through activation of the cholinergic system, offering a new mechanism for pharmacological strategies of this disorder.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16131546      PMCID: PMC1201605          DOI: 10.1073/pnas.0506034102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  56 in total

Review 1.  Pharmacologic treatment of schizophrenia.

Authors:  J M Kane
Journal:  Biol Psychiatry       Date:  1999-11-15       Impact factor: 13.382

2.  Cholinergic modulation of excitatory synaptic transmission in the CA3 area of the hippocampus.

Authors:  K E Vogt; W G Regehr
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

3.  Exposing rats to a predator blocks primed burst potentiation in the hippocampus in vitro.

Authors:  M H Mesches; M Fleshner; K L Heman; G M Rose; D M Diamond
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

4.  Muscarinic tone sustains impulse flow in the septohippocampal GABA but not cholinergic pathway: implications for learning and memory.

Authors:  M Alreja; M Wu; W Liu; J B Atkins; C Leranth; M Shanabrough
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

5.  Effects of the selective M1 muscarinic receptor antagonist dicyclomine on emotional memory.

Authors:  R V Fornari; K M Moreira; M G Oliveira
Journal:  Learn Mem       Date:  2000 Sep-Oct       Impact factor: 2.460

6.  Biphasic modulation of hippocampal plasticity by behavioral stress and basolateral amygdala stimulation in the rat.

Authors:  I Akirav; G Richter-Levin
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

Review 7.  Emerging principles of altered neural circuitry in schizophrenia.

Authors:  F M Benes
Journal:  Brain Res Brain Res Rev       Date:  2000-03

8.  Cholinergic modulation of synaptic transmission and plasticity in entorhinal cortex and hippocampus of the rat.

Authors:  S H Yun; M Y Cheong; I Mook-Jung; K Huh; C Lee; M W Jung
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

Review 9.  Amygdalo-entorhinal inputs to the hippocampal formation in relation to schizophrenia.

Authors:  F M Benes; S Berretta
Journal:  Ann N Y Acad Sci       Date:  2000-06       Impact factor: 5.691

Review 10.  Muscarinic receptors in schizophrenia.

Authors:  B Dean; F P Bymaster; E Scarr
Journal:  Curr Mol Med       Date:  2003-08       Impact factor: 2.222

View more
  13 in total

Review 1.  Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.

Authors:  John E Lisman; Joseph T Coyle; Robert W Green; Daniel C Javitt; Francine M Benes; Stephan Heckers; Anthony A Grace
Journal:  Trends Neurosci       Date:  2008-04-07       Impact factor: 13.837

Review 2.  The anatomy of co-morbid neuropsychiatric disorders based on cortico-limbic synaptic interactions.

Authors:  S Totterdell
Journal:  Neurotox Res       Date:  2006-10       Impact factor: 3.911

Review 3.  Glutamate and schizophrenia: beyond the dopamine hypothesis.

Authors:  Joseph T Coyle
Journal:  Cell Mol Neurobiol       Date:  2006-06-14       Impact factor: 5.046

4.  Kainate receptor-mediated modulation of hippocampal fast spiking interneurons in a rat model of schizophrenia.

Authors:  Barbara Gisabella; Vadim Y Bolshakov; Francine M Benes
Journal:  PLoS One       Date:  2012-03-01       Impact factor: 3.240

5.  Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis.

Authors:  Roberto C Agís-Balboa; Graziano Pinna; Adrian Zhubi; Ekrem Maloku; Marin Veldic; Erminio Costa; Alessandro Guidotti
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-19       Impact factor: 11.205

6.  Characterization of a Novel Mutation in SLC1A1 Associated with Schizophrenia.

Authors:  Parisa Afshari; Marina Myles-Worsley; Ori S Cohen; Josepha Tiobech; Stephen V Faraone; William Byerley; Frank A Middleton
Journal:  Mol Neuropsychiatry       Date:  2015-07-08

7.  Prolonged exposure to NMDAR antagonist suppresses inhibitory synaptic transmission in prefrontal cortex.

Authors:  Yuchun Zhang; M Margarita Behrens; John E Lisman
Journal:  J Neurophysiol       Date:  2008-06-04       Impact factor: 2.714

Review 8.  The evolution of drug development in schizophrenia: past issues and future opportunities.

Authors:  William T Carpenter; James I Koenig
Journal:  Neuropsychopharmacology       Date:  2007-11-28       Impact factor: 7.853

Review 9.  Amygdalocortical circuitry in schizophrenia: from circuits to molecules.

Authors:  Francine M Benes
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

Review 10.  Neuronal Plasticity: Neuronal Organization is Associated with Neurological Disorders.

Authors:  Yogesh Kumar Dhuriya; Divakar Sharma
Journal:  J Mol Neurosci       Date:  2020-06-06       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.